You need to upgrade your Flash Player
-$0.04 (-0.96%)
05:59PM (15 mins delay)
Oct 11, 2009 - 7:46 AM EDT
VFC submits:BDSI: Shares of BioDelivery Sciences headed into the long Columbus Day weekend on an up note after trading over 5% higher on Friday, closing the week at $5-plus. With Onsolis due to launch commercially next week, BDSI's days of trading for below five dollars could be numbered. Investors have thought that before, but it's starting to look like those that held through the post-FDA-approval drop and ensuing volatility could start seeing a reward for their patience. As long as the stock is still trading in the five dollar range, however, I'll be accumulating with a long term outlook (I recently added BDSI to my IRA portfolio).
With the Onsolis approval in the rear view mirror, BioDelivery can concentrate on advancing the pipeline, leaving partner Meda to concentrate on the sales of Onsolis; sales of which BioDelivery will rake in double digit royalties.
Source: Seeking Alpha (Oct 11, 2009 - 7:46 AM EDT)
© 2009 UpDown. All Rights Reserved.
Make a suggestion for this page
Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.
